Ocular toxicity from systemically administered xenobiotics
- PMID: 22803583
- PMCID: PMC4516218
- DOI: 10.1517/17425255.2012.708337
Ocular toxicity from systemically administered xenobiotics
Abstract
Introduction: The eye is considered as the most privileged organ because of the blood-ocular barrier that acts as a barrier to systemically administered xenobiotics. However, there has been a significant increase in the number of reports on systemic drug-induced ocular complications. If such complications are left untreated, then it may cause permanent damage to vision. Hence, knowledge of most recent updates on ever-increasing reports of such toxicities has become imperative to develop better therapy while minimizing toxicities.
Areas covered: The article is mainly divided into anterior and posterior segment manifestations caused by systemically administered drugs. The anterior segment is further elaborated on corneal complications where as the posterior segment is focused on optic nerve, retinal and vitreous complications. Furthermore, this article includes recent updates on acute and chronic ocular predicaments, in addition to discussing various associated symptoms caused by drugs.
Expert opinion: Direct correlation of ocular toxicities due to systemic drug therapy is evident from current literature. Therefore, it is necessary to have detailed documentation of these complications to improve understanding and predict toxicities. We made an attempt to ensure that the reader is aware of the characteristic ocular complications, the potential for irreversible drug toxicity and indications for cessation.
Figures


Similar articles
-
Ocular toxicity assessment from systemically administered xenobiotics: considerations in drug development.Int J Toxicol. 2013 May-Jun;32(3):171-88. doi: 10.1177/1091581813484500. Epub 2013 Apr 24. Int J Toxicol. 2013. PMID: 23616147 Review.
-
Ocular complications of systemic medications.Am J Med Sci. 2011 Jul;342(1):62-9. doi: 10.1097/MAJ.0b013e3181f06b21. Am J Med Sci. 2011. PMID: 21139494 Review.
-
Oculotoxicities of systemically administered drugs.J Ocul Pharmacol. 1986 Fall;2(4):385-404. doi: 10.1089/jop.1986.2.385. J Ocul Pharmacol. 1986. PMID: 3332287 Review.
-
Clinical and genetic determinants of chronic visual pathway changes after methanol - induced optic neuropathy: four-year follow-up study.Clin Toxicol (Phila). 2019 Jun;57(6):387-397. doi: 10.1080/15563650.2018.1532083. Epub 2018 Nov 17. Clin Toxicol (Phila). 2019. PMID: 30451020
-
An assessment of the ocular safety of excipient maleic acid following intravitreal injection in rabbits.Toxicol Pathol. 2012 Jul;40(5):797-806. doi: 10.1177/0192623312441400. Epub 2012 May 2. Toxicol Pathol. 2012. PMID: 22552388
Cited by
-
Is uveitis associated with topiramate use? A cumulative review.Clin Ophthalmol. 2016 Aug 2;10:1467-70. doi: 10.2147/OPTH.S104847. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27536060 Free PMC article.
-
Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment.Arch Toxicol. 2022 Feb;96(2):613-624. doi: 10.1007/s00204-021-03197-8. Epub 2022 Jan 1. Arch Toxicol. 2022. PMID: 34973110 Free PMC article.
-
Ocular Side Effects of Systemic Drugs Used in Dermatology.Indian J Dermatol. 2019 Nov-Dec;64(6):423-430. doi: 10.4103/ijd.IJD_353_18. Indian J Dermatol. 2019. PMID: 31896837 Free PMC article.
-
A Single Drop in the Eye - Effects on the Whole Body?Open Ophthalmol J. 2017 Oct 31;11:305-314. doi: 10.2174/1874364101711010305. eCollection 2017. Open Ophthalmol J. 2017. PMID: 29299077 Free PMC article.
-
Modeling the Effects of Disease, Drug Properties, and Material on Drug Transport From Intraocular Lenses.Transl Vis Sci Technol. 2022 May 2;11(5):14. doi: 10.1167/tvst.11.5.14. Transl Vis Sci Technol. 2022. PMID: 35575775 Free PMC article.
References
-
- Brick DC. Medication errors result in costly claims for ophthalmologists. Surv Ophthalmol. 1995;40(3):232–6. - PubMed
-
- Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007;67(1):75–93. An important review highlighting several retrospective cases and reported adverse effects. - PubMed
-
- Moorthy RS, Valluri S. Ocular toxicity associated with systemic drug therapy. Curr Opin Ophthalmol. 1999;10(6):438–46. This article highlights some of the systemic drug induced ocular side effects. - PubMed
-
- Blomquist PH. Ocular complications of systemic medications. Am J Med Sci. 2011;342(1):62–9. Focus on common ocular side effects are discussed. - PubMed
-
- Garralda Luquin A. Ocular toxicity induced by medication. An Sist Sanit Navar. 2008;31(Suppl 3):147–53. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical